ArticleThe Prostate2017

Neoadjuvant hormonal therapy for low-risk prostate cancer induces biochemical recurrence after radical prostatectomy via increased lymphangiogenesis-related parameters.

Yasuyoshi Miyata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.